The main pathways of the relevant targets in PSD were as follows: hepatitis B (hsa05161), pathways in cancer (hsa05200), pancreatic cancer (hsa05212), bladder cancer (hsa05219), and the TNF signaling pathway (hsa04668). This evidence concerns the gene TNF and familial pancreatic carcinoma.